The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session. Here are some other stocks moving in pre-market ...
TipRanks on MSN23h
Innovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye DiseaseAn announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback